Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 investor letter.

AstraZeneca is showing no signs of restarting a 200 million pound sterling ($273 million) investment in its U.K. hometown, despite keeping its options open. | AstraZeneca is showing no signs of ...

AstraZeneca plans to delist from Nasdaq and move to the NYSE, while its breast cancer drug Enhertu enters European regulatory review after strong trial results.

AstraZeneca is relying on several upcoming products to help hit its target of $80 billion in revenue by 2030, including drugs ...

By Andrew MacAskill LONDON, Jan 26 (Reuters) - UK-headquartered pharmaceutical firm AstraZeneca's CEO Pascal Soriot will join Prime Minister Keir Starmer's trip to China this week, said a source ...

AstraZeneca PLC aims for $80 billion in revenue by 2030, driven by strong growth in oncology, biopharmaceuticals, and rare diseases, despite recent share price declines. The company's weight ...

AstraZeneca (NASDAQ:AZN) has announced it will shift its US listing from Nasdaq to the New York Stock Exchange, delisting its ...

AstraZeneca (AZN) is one of the biggest players in the healthcare sector, whose medicines save the lives of tens of thousands of people every year. In this article, I will share six reasons why I ...

C ambridge, UK-based AstraZeneca plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. The project includes an expansion of its flagship biologics manufacturing ...

Add Yahoo as a preferred source to see more of our stories on Google. We reached out to numerous Latin language experts, all of whom confirmed the same thing: The above translation is wrong and "a ...

LONDON - AstraZeneca’s COVID-19 vaccine provided strong protection against disease and complete protection against hospitalization and death across all age groups in a late-stage U.S. study, the ...